Dr. Muhammad Zafar, M.D.
Claim this profileDuke University Hospital
Studies Epilepsy
Studies Lennox Gastaut Syndrome
7 reported clinical trials
8 drugs studied
Area of expertise
1Epilepsy
TSC1 positive
TSC2 positive
2Lennox Gastaut Syndrome
Affiliated Hospitals
Clinical Trials Muhammad Zafar, M.D. is currently running
Carisbamate
for Lennox-Gastaut Syndrome
The primary objective is to evaluate the efficacy of carisbamate (YKP509) as adjunctive treatment in reducing the number of drop seizures (tonic, atonic, and tonic-clonic) compared with placebo in pediatric and adult subjects (age 4-55 years) diagnosed with Lennox Gastaut Syndrome (LGS).
Recruiting1 award Phase 315 criteria
Pyridoxal Phosphate
for Pyridoxine 5'-Phosphate Oxidase Deficiency
The proposed clinical study is intended to evaluate oral P5P for the treatment of patients confirmed to have Pyridox(am)ine 5'-Phosphate Oxidase (PNPO) deficiency via genetic analysis. There is an unmet clinical need for pharmaceutical grade P5P, as to date none has been made commercially available. Patients will receive pharmaceutical grade P5P according to their normal oral P5P dosing regimen, as previously established by their physicians.
Recruiting2 awards Phase 3
More about Muhammad Zafar, M.D.
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Muhammad Zafar, M.D. has experience with
- Carisbamate
- Diazepam Nasal Spray [Valtoco]
- JBPOS0101
- Cenobamate
- Pyridoxal Phosphate
- Ganaxalone
Breakdown of trials Muhammad Zafar, M.D. has run
Epilepsy
Lennox Gastaut Syndrome
Arterial Tortuosity Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Muhammad Zafar, M.D. specialize in?
Muhammad Zafar, M.D. focuses on Epilepsy and Lennox Gastaut Syndrome. In particular, much of their work with Epilepsy has involved TSC1 positive patients, or patients who are TSC2 positive.
Is Muhammad Zafar, M.D. currently recruiting for clinical trials?
Yes, Muhammad Zafar, M.D. is currently recruiting for 3 clinical trials in Durham North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Muhammad Zafar, M.D. has studied deeply?
Yes, Muhammad Zafar, M.D. has studied treatments such as Carisbamate, Diazepam Nasal Spray [Valtoco], JBPOS0101.
What is the best way to schedule an appointment with Muhammad Zafar, M.D.?
Apply for one of the trials that Muhammad Zafar, M.D. is conducting.
What is the office address of Muhammad Zafar, M.D.?
The office of Muhammad Zafar, M.D. is located at: Duke University Hospital, Durham, North Carolina 27710 United States. This is the address for their practice at the Duke University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.